FDA Drug Application (203214) for XELJANZ by PF PRISM CV

Back to FDA Applications sponsored by PF PRISM CV

Application Number203214
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameXELJANZ
Active IngredientTOFACITINIB CITRATE

Active IngredientCount
List of drugs with Active Ingredient TOFACITINIB CITRATE2


Back to FDA Applications sponsored by PF PRISM CV